应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02171 科济药业-B
休市中 01-09 16:08:35
16.460
+0.080
+0.49%
最高
16.500
最低
15.900
成交量
154.91万
今开
16.380
昨收
16.380
日振幅
3.66%
总市值
93.82亿
流通市值
93.82亿
总股本
5.70亿
成交额
2,518万
换手率
0.27%
流通股本
5.70亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 科济药业-B 01月08日卖空量成交4.5万股,卖空比例为2.91%
市场透视 · 01-08
每日卖空追踪 | 科济药业-B 01月08日卖空量成交4.5万股,卖空比例为2.91%
科济药业-B01月08日主力净流出397.3万元 散户资金买入
市场透视 · 01-08
科济药业-B01月08日主力净流出397.3万元 散户资金买入
科济药业(02171)公布2025年12月股份变动月报,期末合计约5.78亿股
公告速递 · 01-07
科济药业(02171)公布2025年12月股份变动月报,期末合计约5.78亿股
每日卖空追踪 | 科济药业-B 01月07日卖空量成交4.95万股,卖空比例为5.58%
市场透视 · 01-07
每日卖空追踪 | 科济药业-B 01月07日卖空量成交4.95万股,卖空比例为5.58%
科济药业-B01月06日主力净流出140.9万元 散户资金买入
市场透视 · 01-06
科济药业-B01月06日主力净流出140.9万元 散户资金买入
每日卖空追踪 | 科济药业-B 01月05日卖空量成交12.4万股,卖空比例为5.32%
市场透视 · 01-05
每日卖空追踪 | 科济药业-B 01月05日卖空量成交12.4万股,卖空比例为5.32%
科济药业-B01月05日主力净流入43.8万元 散户资金抛售
市场透视 · 01-05
科济药业-B01月05日主力净流入43.8万元 散户资金抛售
科济药业-B(02171.HK)涨近6%
每日经济新闻 · 01-05
科济药业-B(02171.HK)涨近6%
港股异动 | 科济药业-B(02171)涨近6% 近日攻关实体瘤免疫细胞治疗新药 项目获列入国家科技重大专项
智通财经 · 01-05
港股异动 | 科济药业-B(02171)涨近6% 近日攻关实体瘤免疫细胞治疗新药 项目获列入国家科技重大专项
每日卖空追踪 | 科济药业-B 01月02日卖空量成交5.25万股,卖空比例为5.79%
市场透视 · 01-02
每日卖空追踪 | 科济药业-B 01月02日卖空量成交5.25万股,卖空比例为5.79%
每日卖空追踪 | 科济药业-B 12月30日卖空量成交2.9万股,卖空比例为3.38%
市场透视 · 2025-12-30
每日卖空追踪 | 科济药业-B 12月30日卖空量成交2.9万股,卖空比例为3.38%
科济药业提交通用型BCMA CAR-T产品两项IND申请
细胞治疗前沿 · 2025-12-30
科济药业提交通用型BCMA CAR-T产品两项IND申请
科济药业-B(02171)12月29日斥资484.77万港元回购32.6万股
智通财经 · 2025-12-29
科济药业-B(02171)12月29日斥资484.77万港元回购32.6万股
科济药业控股(2171)回购32.6万股股份,涉及金额约484.8万港元
公告速递 · 2025-12-29
科济药业控股(2171)回购32.6万股股份,涉及金额约484.8万港元
非执行董事郭华清增持科济药业(02171)3万股 每股作价15.09港元
智通财经 · 2025-12-24
非执行董事郭华清增持科济药业(02171)3万股 每股作价15.09港元
每日卖空追踪 | 科济药业-B 12月24日卖空量成交6.15万股,卖空比例为16.96%
市场透视 · 2025-12-24
每日卖空追踪 | 科济药业-B 12月24日卖空量成交6.15万股,卖空比例为16.96%
智通港股回购统计|12月24日
智通财经 · 2025-12-24
智通港股回购统计|12月24日
科济药业-B(02171)12月23日斥资486.09万港元回购32万股
智通财经 · 2025-12-23
科济药业-B(02171)12月23日斥资486.09万港元回购32万股
天价“抗癌针”成本有望降至万元以内——专访科济药业董事会主席李宗海
中国基金报 · 2025-12-23
天价“抗癌针”成本有望降至万元以内——专访科济药业董事会主席李宗海
非执行董事郭华清增持科济药业(02171)1.8万股 每股作价14.52港元
智通财经网 · 2025-12-22
非执行董事郭华清增持科济药业(02171)1.8万股 每股作价14.52港元
加载更多
公司概况
公司名称:
科济药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。该公司的主营业务是开发嵌合抗原受体T细胞(CAR-T)细胞疗法,以满足临床需求,包括但不限于血液恶性肿瘤、实体瘤及自身免疫性疾病。该公司的主要产品包括赛恺泽(泽沃基奥仑赛注射液)、舒瑞基奥仑赛注射液、通用型CAR-T细胞产品。该公司在中国和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"科济药业-B","latestPrice":16.46,"timestamp":1767946115005,"preClose":16.38,"halted":0,"volume":1549065,"delay":0,"floatShares":570000000,"shares":570000000,"eps":-1.612929808782146,"marketStatus":"休市中","change":0.08,"latestTime":"01-09 16:08:35","open":16.38,"high":16.5,"low":15.9,"amount":25184373,"amplitude":0.03663,"askPrice":16.46,"askSize":24000,"bidPrice":16.37,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-1.060422786651388,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":7,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":16.38,"openAndCloseTimeList":[[1767922200000,1767931200000],[1767934800000,1767945600000]],"volumeRatio":1.0807832385139475,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171","defaultTab":"news","newsList":[{"id":"2602840340","title":"每日卖空追踪 | 科济药业-B 01月08日卖空量成交4.5万股,卖空比例为2.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602840340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602840340?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861029,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月08日,跌1.15%,卖空量成交4.5万股,较上一交易日减少65.12%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164710a7023cef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164710a7023cef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1585","02171","BK1161"],"gpt_icon":0},{"id":"2602347002","title":"科济药业-B01月08日主力净流出397.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2602347002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602347002?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:16","pubTimestamp":1767860167,"startTime":"0","endTime":"0","summary":"01月08日, 科济药业-B股价跌1.15%,报收16.38元,成交金额2688.0万元,换手率0.28%,振幅3.74%,量比1.16。科济药业-B今日主力资金净流出397.3万元,上一交易日主力净流出0万元。该股近5个交易日上涨11.78%,主力资金累计净流出494.4万元;近20日主力资金累计净流入1195.4万元,其中净流入天数为11日。该股主力净额占比0.04%,港股市场排名2578/2713。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108163136a4ab34ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108163136a4ab34ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02171","BK1574","BK1161","BK1585"],"gpt_icon":0},{"id":"1141274335","title":"科济药业(02171)公布2025年12月股份变动月报,期末合计约5.78亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1141274335","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141274335?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:56","pubTimestamp":1767783392,"startTime":"0","endTime":"0","summary":"科济药业控股有限公司于2026年1月7日呈交截至2025年12月31日的股份变动月报表。报告显示,公司法定股本维持在2000亿股,折合注册股本5万美元,未见调整。两项合并后,于2025年12月31日,公司总股本为578,116,999股,较上月底增加143,844股。另据月报,公司于期内多次回购普通股,其中455,000股尚未注销,余数已被持作库存股份。截至报告期末,公司确认所有股份发行及回购满足相关上市规则及法律法规要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"gpt_icon":0},{"id":"2601336227","title":"每日卖空追踪 | 科济药业-B 01月07日卖空量成交4.95万股,卖空比例为5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601336227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601336227?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774628,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月07日,涨4.61%,卖空量成交4.95万股,较上一交易日减少86.64%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163406a6fdde1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163406a6fdde1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1587","02171","BK1585"],"gpt_icon":0},{"id":"2601814727","title":"科济药业-B01月06日主力净流出140.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2601814727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601814727?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:15","pubTimestamp":1767687355,"startTime":"0","endTime":"0","summary":"01月06日, 科济药业-B股价跌3.83%,报收15.84元,成交金额2222.2万元,换手率0.24%,振幅6.50%,量比1.01。科济药业-B今日主力资金净流出140.9万元,上一交易日主力净流入43.8万元。该股近5个交易日上涨6.65%,主力资金累计净流出145.2万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1476.0万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162225a4a27b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162225a4a27b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02171","BK1587","BK1585","BK1161"],"gpt_icon":0},{"id":"2601883308","title":"每日卖空追踪 | 科济药业-B 01月05日卖空量成交12.4万股,卖空比例为5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601883308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601883308?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601827,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月05日,涨7.51%,卖空量成交12.4万股,较上一交易日减少13.59%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163523a49e2936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163523a49e2936&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1161","BK1585","02171"],"gpt_icon":0},{"id":"2601488887","title":"科济药业-B01月05日主力净流入43.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601488887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601488887?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:15","pubTimestamp":1767600927,"startTime":"0","endTime":"0","summary":"01月05日, 科济药业-B股价涨7.51%,报收16.47元,成交金额3800.5万元,换手率0.42%,振幅9.66%,量比2.26。科济药业-B今日主力资金净流入43.8万元,上一交易日主力净流出0万元。该股近5个交易日上涨9.01%,主力资金累计净流出105.9万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1660.3万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105161731a6f50ee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105161731a6f50ee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1585","02171","BK1161","BK1587"],"gpt_icon":0},{"id":"2601074581","title":"科济药业-B(02171.HK)涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601074581","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601074581?lang=zh_cn&edition=full","pubTime":"2026-01-05 11:29","pubTimestamp":1767583766,"startTime":"0","endTime":"0","summary":"每经AI快讯,科济药业-B(02171.HK)涨近6%,截至发稿涨5.94%,报16.23港元,成交额1880.74万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601053608593059.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608593059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1587","02171","BK1574","BK1161","BK1585"],"gpt_icon":0},{"id":"2601071458","title":"港股异动 | 科济药业-B(02171)涨近6% 近日攻关实体瘤免疫细胞治疗新药 项目获列入国家科技重大专项","url":"https://stock-news.laohu8.com/highlight/detail?id=2601071458","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601071458?lang=zh_cn&edition=full","pubTime":"2026-01-05 11:21","pubTimestamp":1767583270,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科济药业-B涨近6%,截至发稿,涨5.94%,报16.23港元,成交额1880.74万港元。消息面上,12月30日,据科济药业官微消息,公司宣布,由旗下上海科济制药有限公司牵头申报的“实体肿瘤的免疫细胞治疗关键技术和 创新药 研发”项目,正式获批列入创新药物研发国家科技重大专项2025年度项目立项清单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1585","BK1161","02171","BK1574"],"gpt_icon":0},{"id":"2600099294","title":"每日卖空追踪 | 科济药业-B 01月02日卖空量成交5.25万股,卖空比例为5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600099294","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600099294?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:30","pubTimestamp":1767342629,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间01月02日,涨3.16%,卖空量成交5.25万股,较上一交易日减少46.7%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163326a6eb2a57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163326a6eb2a57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1587","02171","BK1585"],"gpt_icon":0},{"id":"2595943027","title":"每日卖空追踪 | 科济药业-B 12月30日卖空量成交2.9万股,卖空比例为3.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595943027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595943027?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083427,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间12月30日,跌2.15%,卖空量成交2.9万股,较上一交易日减少91.34%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163358a4897e98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163358a4897e98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","02171","BK1161","BK1585"],"gpt_icon":0},{"id":"2595279451","title":"科济药业提交通用型BCMA CAR-T产品两项IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2595279451","media":"细胞治疗前沿","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595279451?lang=zh_cn&edition=full","pubTime":"2025-12-30 09:27","pubTimestamp":1767058038,"startTime":"0","endTime":"0","summary":"2025年12月29日,科济药业宣布已向国家药品监督管理局提交通用型BCMA CAR-T产品CT0596的两项新药临床试验申请,以分别启动治疗复发/难治性多发性骨髓瘤及原发性浆细胞白血病的Ib/Ⅱ期临床试验。除了通用型管线,科济药业的自体CAR-T产品也已取得实质性进展。舒瑞基奥仑赛注射是全球首款进入NDA阶段的用于治疗实体瘤的CAR-T细胞产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230110444a6df6074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230110444a6df6074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02171","BK1587","BK1161","BK1585"],"gpt_icon":0},{"id":"2595738635","title":"科济药业-B(02171)12月29日斥资484.77万港元回购32.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595738635","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595738635?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:22","pubTimestamp":1767014545,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B(02171)发布公告,于2025年12月29日该公司斥资484.77万港元回购32.6万股,回购价格为每股14.78-14.91港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02171","BK1587","BK1574","BK1161","BK1585"],"gpt_icon":0},{"id":"1152258719","title":"科济药业控股(2171)回购32.6万股股份,涉及金额约484.8万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152258719","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152258719?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:21","pubTimestamp":1767014479,"startTime":"0","endTime":"0","summary":"科济药业控股有限公司于2025年12月29日发布翌日披露报表,公告回购32.6万股股份,约占当日前已发行股份的0.06%。本次回购价格介乎每股14.78至14.91港元,合计动用约484.8万港元资金。截至本次回购,科济药业控股已累计回购约8,273,000股股份,占授权通过日已发行股本的1.438%。公司在公告中确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。本次公告由执行董事李宗海签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"gpt_icon":0},{"id":"2593715224","title":"非执行董事郭华清增持科济药业(02171)3万股 每股作价15.09港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593715224","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593715224?lang=zh_cn&edition=full","pubTime":"2025-12-24 19:26","pubTimestamp":1766575575,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,12月19日,非执行董事郭华清增持科济药业(02171)3万股,每股作价15.09港元,总金额为45.27万港元。增持后最新持股数目约为2.26亿股,持股比例为39.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","02171","BK1585","BK1587"],"gpt_icon":0},{"id":"2594287469","title":"每日卖空追踪 | 科济药业-B 12月24日卖空量成交6.15万股,卖空比例为16.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594287469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594287469?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565026,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间12月24日,跌0.85%,卖空量成交6.15万股,较上一交易日减少80.51%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163421a472800b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163421a472800b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02171","BK1585","BK1574","BK1161"],"gpt_icon":0},{"id":"2593944268","title":"智通港股回购统计|12月24日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593944268","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593944268?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:10","pubTimestamp":1766538601,"startTime":"0","endTime":"0","summary":"其中,回购金额最大的为腾讯控股,回购数量105.10 万,回购金额6.36 亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385264.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00697","01583","01600","02219","02251","02038","00947","02419","02121","09878","01995","01919","02416","02886","00314","01773","01588","06868","02869","02018","01458","02171","01024","09886","02167","06826","01672","09857","02392","09959","02367","09896","02598","00345","01651","00434","00909","00732","01317","02299","00700","03888","06078","06100","00799","01907","02678","00175","01810","09923"],"gpt_icon":1},{"id":"2593418349","title":"科济药业-B(02171)12月23日斥资486.09万港元回购32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418349","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593418349?lang=zh_cn&edition=full","pubTime":"2025-12-23 21:16","pubTimestamp":1766495776,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B(02171)发布公告,于2025年12月23日该公司斥资486.09万港元回购32万股,回购价格为每股14.98-15.25港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385151.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK1585","02171","BK1587"],"gpt_icon":0},{"id":"2593497198","title":"天价“抗癌针”成本有望降至万元以内——专访科济药业董事会主席李宗海","url":"https://stock-news.laohu8.com/highlight/detail?id=2593497198","media":"中国基金报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593497198?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:23","pubTimestamp":1766492630,"startTime":"0","endTime":"0","summary":"【导读】科济药业董事会主席李宗海:通用型CAR-T产品有望将成本降至1万元/针左右作为革命性的癌症免疫治疗方法,CAR-T细胞疗法被认为是目前最有前景的肿瘤治疗方式之一,但其高达百万元的治疗费用却让众多普通患者望而却步。不过,此种状况有望迎来积极的变化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233599719764.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599719764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","02171","BK1587","BK1585","BK1161"],"gpt_icon":0},{"id":"2593481733","title":"非执行董事郭华清增持科济药业(02171)1.8万股 每股作价14.52港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593481733","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593481733?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:06","pubTimestamp":1766401576,"startTime":"0","endTime":"0","summary":"12月18日,非执行董事郭华清增持科济药业(02171)1.8万股,每股作价14.52港元,总金额约为26.14万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20251222/20251222190654_25742.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251222/20251222190654_25742.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"非执行董事郭华清增持科济药业(02171)1.8万股 每股作价14.52港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1587","BK1574","BK1161","BK1585","02171"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":0.0744},{"period":"1month","weight":-0.0318},{"period":"3month","weight":-0.0876},{"period":"6month","weight":-0.2272},{"period":"1year","weight":0.7548},{"period":"ytd","weight":0.1084}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.0022},{"period":"6month","weight":0.0867},{"period":"1year","weight":0.3633},{"period":"ytd","weight":0.0235}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。该公司的主营业务是开发嵌合抗原受体T细胞(CAR-T)细胞疗法,以满足临床需求,包括但不限于血液恶性肿瘤、实体瘤及自身免疫性疾病。该公司的主要产品包括赛恺泽(泽沃基奥仑赛注射液)、舒瑞基奥仑赛注射液、通用型CAR-T细胞产品。该公司在中国和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.065651},{"month":2,"riseRate":0.75,"avgChangeRate":0.310052},{"month":3,"riseRate":0,"avgChangeRate":-0.128154},{"month":4,"riseRate":0.25,"avgChangeRate":-0.092431},{"month":5,"riseRate":0.75,"avgChangeRate":0.085205},{"month":6,"riseRate":0.5,"avgChangeRate":0.033426},{"month":7,"riseRate":0.4,"avgChangeRate":-0.015336},{"month":8,"riseRate":0.6,"avgChangeRate":0.066197},{"month":9,"riseRate":0.4,"avgChangeRate":0.033481},{"month":10,"riseRate":0.6,"avgChangeRate":0.024843},{"month":11,"riseRate":0.6,"avgChangeRate":0.051023},{"month":12,"riseRate":0.4,"avgChangeRate":-0.058482}],"exchange":"SEHK","name":"科济药业-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科济药业-B,02171,科济药业-B股票,科济药业-B股票老虎,科济药业-B股票老虎国际,科济药业-B行情,科济药业-B股票行情,科济药业-B股价,科济药业-B股市,科济药业-B股票价格,科济药业-B股票交易,科济药业-B股票购买,科济药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}